Phase Code: SCF-CF-AEROVIA201-EBP-P2-0001
Objective: Isolate, classify, and prioritize bioactive molecular classes from Phase 1 ethnobioprospecting sources for development into an inhalable neutrophil elastase-modulating API.
2.1 Source Material Selection
Source | Target Compound Class | Development Relevance |
Croton lechleri | Taspine, proanthocyanidins | Tissue repair, ECM protection |
Himatanthus sucuuba | Iridoids | Cytokine modulation |
Copaifera spp. | Sesquiterpenes, diterpenes | Anti-inflammatory signaling |
Uncaria tomentosa | Oxindole alkaloids | Immune modulation |
Mikania glomerata | Diterpenes, coumarin-like compounds | Respiratory-support pharmacology |
2.2 Extraction Strategy
Compound Polarity | Extraction Method | Analytical Confirmation |
Alkaloids | Ethanol/water extraction, acid-base fractionation | HPLC-MS, LC-MS/MS |
Terpenes | Supercritical CO₂ or hexane extraction | GC-MS, LC-MS |
Iridoids | Aqueous ethanol extraction | HPLC-MS |
Proanthocyanidins | Ethanol/water extraction | HPLC-DAD, LC-MS/MS |
Diterpenes | Ethanol or supercritical CO₂ | LC-MS, NMR |
2.3 MoA / MeA Profiling
Candidate Class | Mode of Action | Mechanism of Action Hypothesis |
Taspine derivatives | Tissue-protective | Modulates epithelial repair and ECM stabilization |
Iridoids | Anti-inflammatory | Reduces cytokine amplification and NF-κB-associated signaling |
Copaiba terpenes | Inflammatory harmonization | Suppresses excess neutrophilic signaling |
Oxindole alkaloids | Immune modulation | Modulates cytokine drift and immune overactivation |
Respiratory diterpenes | Airway support | Reduces airway inflammatory tone |
2.4 SCF Role Assignment
Candidate Class | Primary SCF Role | Secondary Role |
Taspine derivatives | Restorative Modulator | Safety Harmonizer |
Iridoids | Safety Harmonizer | Anti-fibrotic Support |
Copaiba terpenes | Safety Harmonizer | Metabolic Regulator |
Oxindole alkaloids | Immune Modulator | Resistance Prevention Support |
Respiratory diterpenes | Pulmonary Support Agent | Absorption/Delivery Support |
2.5 AEROVIA-201 Lead-Relevance Filter
For TCP-201, compounds must show relevance to:
Filter | Requirement |
Elastase modulation | Direct or indirect reduction of elastase-mediated injury |
Protease selectivity | Avoid broad protease shutdown |
Pulmonary suitability | Compatible with inhaled formulation |
ECM preservation | Reduces elastin/collagen degradation signaling |
Host-defense preservation | Does not impair antimicrobial immune function |
Chronic-use potential | Suitable for long-term CF therapy |
2.6 Priority Extract/Fraction Ranking
Rank | Fraction | Priority | Rationale |
1 | Croton lechleri taspine-enriched fraction | Very High | Best tissue-repair and ECM-preservation translation |
2 | Himatanthus sucuuba iridoid fraction | Very High | Cytokine and fibrotic-signal relevance |
3 | Copaifera spp. terpene fraction | High | Strong anti-inflammatory compatibility |
4 | Uncaria tomentosa oxindole alkaloid fraction | High | Immune harmonization |
5 | Mikania glomerata diterpene fraction | Moderate–High | Respiratory domain support |
2.7 Phase 2 Experimental Screening Panel
Assay | Purpose |
Neutrophil elastase enzymatic assay | Detect direct elastase inhibition/modulation |
Elastin degradation assay | Measure ECM-protective effect |
CF bronchial epithelial cell assay | Assess cytoprotection and airway safety |
IL-8 / TNF-α / IL-6 cytokine panel | Measure inflammatory modulation |
MMP-9 assay | Assess downstream protease-network suppression |
Sputum-mimetic stability assay | Evaluate CF airway compatibility |
Antimicrobial preservation assay | Confirm host-defense compatibility |
2.8 Preliminary SCF Analysis
SCF Principle | Phase 2 Interpretation |
Targeted Drug Action | Prioritize fractions reducing elastase-mediated airway damage |
Pharmacokinetic Optimization | Favor inhalation-compatible, lung-retentive molecules |
Metabolic Efficiency | Favor low systemic exposure and non-CYP-heavy metabolism |
Resistance Prevention | Avoid broad immune suppression or microbiome destabilization |
Safety Profile | Prioritize epithelial safety and chronic-use tolerability |
Phase 2 Decision
Selected lead molecular direction:
Taspine/iridoid-inspired synthetic scaffold program with terpene-supported anti-inflammatory harmonization.
Primary next objective:
Convert active fractions into defined molecular hits and perform SCF synergy scoring.
PROCEED TO PHASE 3 — SYNERGY METRICS COMPUTATION
MASTER REGISTRY INDEX
SCF-CF-AEROVIA201-EBP-P2-0001 — Compound Extraction & SCF Analysis
SCF-CF-API-201 — AEROVIA-201 Pulmonary Neutrophil Elastase Modulator
SCF-EXTR-MOA-MEA-0001 — Botanical MoA/MeA Extraction Protocol
SCF-SEF-MD-0001 — Synergistic Evaluation Framework
SCF-PATH-UT-0001 — SCF Pathophysiology Protocol